The U.K. government has secured an extra 60 million doses of the vaccine produced by Pfizer Inc. and BioNTech SE to form part of a booster program to protect the most vulnerable people against Covid-19 before winter.
Scientists advising the government are deciding which groups of people should get the booster shot later this year, after they have been given their first two doses.
